Bottomline Technologies Announces New Releases of Logical Ink® and MedEx®

Bottomline Technologies (NASDAQ: EPAY), a leading provider of cloud-based payment, invoice and banking solutions, today announced general availability of Logical Ink 4.6 and MedEx 4.0, the newest releases of the company’s flagship mobile and on-demand document automation solutions for healthcare organizations. Bottomline’s solutions are helping more than 1,500 healthcare organizations improve business efficiencies, reduce costs and improve care quality.

With Logical Ink, the experience of capturing discrete patient data and the electronic signatures required for documentation can be mobile-enabled for patients, staff and caregivers. Windows^®-based tablets, digital ink, and a pen-based interface deliver a simple, intuitive user experience that’s as natural and unrestrictive as paper, with all the benefits of mobility, including immediate data validation at the point of care.

With MedEx, clinical staff can easily access and output standardized documents, barcoded patient wristbands, and labels that include up-to-date information. Documents that reflect the most current data ensure positive patient identification and allow hospitals to optimize the efficiency of document-driven processes across the continuum of care. MedEx’s automatic indexing capabilities also enable healthcare facilities to eliminate the expense and management hassles of pre-printed forms and significantly reduce time-consuming document preparation, scanning and filing tasks.

"With these releases we have expanded functionality across our patient registration solutions — from the user interface to the supported underlying technologies — to enrich the user experience and extend our customers’ return on investment. Logical Ink now offers customers even more options to deploy mobile data capture capabilities for both e-signatures and consents, as well as more complex form completion. MedEx 4.0 also embraces a clear upgrade path from previous releases so that all customers can benefit,” said Michael Kortan, Vice President of Healthcare for Bottomline.

Highlights of the Logical Ink 4.6 release include new functionality for Microsoft Word import, support for Topaz^® signature pads, advanced synchronization for off-line use, and enhanced patient data models to support multi-facility and enterprise deployments. Highlights of the MedEx 4 release include an updated user interface to improve usability, improved HL7 processing performance and scalability, and enhanced ability to manage patient data entry and updates in the downtime registration function.

For more information on Bottomline’s healthcare solutions, please visit www.bottomline.com/healthcare_solutions.html.

Editorial Note: Bottomline will be exhibiting in booth #2619 (Hall D) at HIMSS13; March 3-7, 2013 in New Orleans. For more information or to arrange an on-site meeting, please contact Deidre Moore at dmoore@bottomline.com.

About Bottomline Technologies
Bottomline Technologies (NASDAQ: EPAY) provides cloud-based payment, invoice and banking solutions to corporations, financial institutions and banks around the world. The company’s solutions are used to streamline, automate and manage processes involving payments, invoicing, global cash management, supply chain finance and transactional documents. Organizations trust Bottomline to meet their needs for cost reduction, competitive differentiation and optimization of working capital. Headquartered in the United States, Bottomline also maintains offices in Europe and Asia-Pacific. For more information, visit www.bottomline.com.

Bottomline Technologies, MedEx, Logical Ink and the Bottomline Technologies logo are trademarks of Bottomline Technologies (de), Inc. which may be registered in certain jurisdictions. All other brand/product names may be trademarks of their respective owners.

Cautionary Language
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from our expectations as a result of various important factors, including but not limited to competition, market demand, technological change, strategic relationships, recent acquisitions, international operations and general economic conditions. For additional discussion of these and other factors that could impact our operational and financial results, refer to our filings with the Securities and Exchange Commission, including our Form 10-K for the fiscal year ended June 30, 2012 and subsequent filings. Any forward-looking statements represent our views only as of today and we do not assume any obligation to update such statements.